Reneo to start pivotal trial in mitochondrial diseases, build orphan pipeline with Novo, Abingworth-led $95M series B
Company names Greg Flesher CEO
Reneo has designs on becoming a commercially-oriented, publicly traded company with multiple programs rather than a single-asset play.
Dec 9, 2020 | 8:46 PM GMT
With $95 million in